Press Releases

GlobeNewswire, Inc.

First patient dosed in Phase 2 clinical trial of rinvatercept in patients with Duchenne muscular dystrophy in September 2026 Nominated KER-206, a novel ligand trap designed to bind select TGF-β ligands to regulate bone remodeling, from nonclinical...

GlobeNewswire, Inc.

MINNEAPOLIS, Nov. 05, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with...

GlobeNewswire, Inc.

Advancing a pipeline built entirely on the Alector Brain Carrier (ABC) blood-brain barrier platform, spanning antibody, enzyme, and siRNA programs, with AL137, Alector's lead ABC-enabled anti-amyloid beta (Aβ) antibody program for Alzheimer's...

GlobeNewswire, Inc.

Topline data from 400-person sentinel safety cohort and approximately 5,000 patients in main cohort Phase 2b COVID-19 trial anticipated by mid-year 2027 Expanded intellectual property portfolio with new European patent that further protects core...

GlobeNewswire, Inc.

AMPLIFY-7P Phase 2 pre-specified analyses demonstrate substantial reductions in risk of recurrence or death in ctDNA negative patients and patients without prior radiation, enabling a targeted Phase 3 strategy in adjuvant PDAC; findings presented...

GlobeNewswire, Inc.

EMERYVILLE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- NMI Holdings, Inc. (Nasdaq: NMIH) today reported net income of $93.5 million, or $1.23 per diluted share, for the third quarter ended September 30, 2026, compared to $105.8 million, or $1.38...

GlobeNewswire, Inc.

Pivotal Phase 2 ALPHA3 Program in 1L Large B-cell Lymphoma (LBCL): ALPHA3 Enrollment Momentum Continues, Supported by Expanding Trial Network, Increased MRD Screening, and Brisk Enrollment in Asia-Pacific Next ALPHA3 Clinical Update Anticipated in...

GlobeNewswire, Inc.

Strengthened research and development (R&D) leadership by appointing Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development Received third-party recognition of INB-619 in a Nature Reviews Drug Discovery review of...

GlobeNewswire, Inc.

Reported favorable safety, tolerability and pharmacokinetic (“PK”) results from the single ascending-dose portion of the TX2100 Phase 1a clinical trial in healthy adult volunteers; FDA granted TX2100 Fast Track designation for Hereditary...

GlobeNewswire, Inc.

WOODBURY, N.Y., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its third quarter of 2026. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial...

GlobeNewswire, Inc.

Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes (T1D) completed enrollment with 166 participants randomized; topline results expected mid 2027 Randomized the first participant in its Phase 2a Hybrid CATT1 pilot...

GlobeNewswire, Inc.

Best-in-disease results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 studies showed rapid, profound, sustained efficacy supporting barzolvolimab’s potential to be a transformational therapy in CSU BLA submission for barzolvolimab in CSU anticipated in...

GlobeNewswire, Inc.

SAN JOSE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a hybrid cloud leader and AI platform company, today announced that it will report its financial results for the first quarter of fiscal year 2027, which ended...

Nevada Attorney General

Carson City, NV – Attorney General Aaron D. Ford has joined a coalition of 20 states and Washington D.C. in a lawsuit to stop the Trump administration from gutting a law that helps police and prosecutors catch money launderers, fraudsters, and tax...

Federal Reserve Board

November 05, 2026 Federal Reserve Board announces termination of enforcement action with Allegiant United Holdings, LLC, Nano Financial Holdings, Inc., and Nano Banc For release at 11:00 a.m. EST The Federal Reserve Board on Thursday announced the...

GlobeNewswire, Inc.

COPENHAGEN, Denmark, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report third quarter 2026 financial results and provide a business update on Thursday, November 12, 2026, before the open of the...

GlobeNewswire, Inc.

NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Greystone, a leading national commercial real estate finance company, has provided a $47,490,000 Freddie Mac loan to finance the acquisition of Foxboro Apartments, a 400-unit multifamily property in...

GlobeNewswire, Inc.

Q3 Revenue of $18.4 million, reflecting continued portfolio rationalization and timing of project deliveries.

GlobeNewswire, Inc.

ROMEOVILLE, Ill., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the...

EIN Presswire

Unified AI agent platform helps SAP ECC and S/4HANA enterprises automate business processes with human approvals, auditable actions and a shadow-mode deployment IRVINE, CA, UNITED STATES, November 5, 2026 /⁨EINPresswire.com⁩/ -- Artificio Products...